Lama Misba

2.5k total citations · 1 hit paper
16 papers, 1.9k citations indexed

About

Lama Misba is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Lama Misba has authored 16 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Biomedical Engineering and 7 papers in Molecular Biology. Recurrent topics in Lama Misba's work include Photodynamic Therapy Research Studies (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Bacterial biofilms and quorum sensing (4 papers). Lama Misba is often cited by papers focused on Photodynamic Therapy Research Studies (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Bacterial biofilms and quorum sensing (4 papers). Lama Misba collaborates with scholars based in India and United States. Lama Misba's co-authors include Asad U. Khan, Divakar Sharma, Sahar Zaidi, Shatavari Kulshrestha, Shakir Khan, Shabbir Ahmad, Sadaf Hasan, Asif Ali, Shahper N. Khan and Kafil Akhtar and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Applied Microbiology and Biotechnology and Drug Discovery Today.

In The Last Decade

Lama Misba

16 papers receiving 1.9k citations

Hit Papers

Antibiotics versus biofilm: an emerging battleground in m... 2019 2026 2021 2023 2019 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lama Misba India 14 841 474 341 317 256 16 1.9k
Luigina Cellini Italy 34 928 1.1× 384 0.8× 303 0.9× 218 0.7× 128 0.5× 128 4.0k
Robert P. Howlin United Kingdom 11 918 1.1× 428 0.9× 131 0.4× 339 1.1× 137 0.5× 16 1.8k
Klaus Kirketerp‐Møller Denmark 23 1.9k 2.2× 264 0.6× 236 0.7× 452 1.4× 321 1.3× 57 3.9k
Kasper Nørskov Kragh Denmark 29 1.6k 1.9× 236 0.5× 364 1.1× 323 1.0× 430 1.7× 64 2.6k
Carol A. Stremick Canada 9 1.5k 1.8× 239 0.5× 187 0.5× 397 1.3× 417 1.6× 10 2.5k
Hengzhuang Wang Denmark 14 1.2k 1.4× 179 0.4× 371 1.1× 348 1.1× 486 1.9× 24 1.9k
Morten Rybtke Denmark 25 1.8k 2.1× 235 0.5× 224 0.7× 365 1.2× 520 2.0× 44 2.4k
Claudia Vuotto Italy 23 1.2k 1.5× 268 0.6× 125 0.4× 302 1.0× 601 2.3× 33 2.5k
Mara Di Giulio Italy 27 598 0.7× 346 0.7× 107 0.3× 188 0.6× 103 0.4× 74 2.3k
Muhammad Asif Nawaz Pakistan 17 1.0k 1.2× 325 0.7× 78 0.2× 340 1.1× 167 0.7× 76 2.1k

Countries citing papers authored by Lama Misba

Since Specialization
Citations

This map shows the geographic impact of Lama Misba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lama Misba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lama Misba more than expected).

Fields of papers citing papers by Lama Misba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lama Misba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lama Misba. The network helps show where Lama Misba may publish in the future.

Co-authorship network of co-authors of Lama Misba

This figure shows the co-authorship network connecting the top 25 collaborators of Lama Misba. A scholar is included among the top collaborators of Lama Misba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lama Misba. Lama Misba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Misba, Lama, et al.. (2024). The dual role of photodynamic therapy to treat cancer and microbial infection. Drug Discovery Today. 29(8). 104099–104099. 10 indexed citations
2.
Misba, Lama & Asad U. Khan. (2023). Domestic LED bulb induced photodynamic effect of Toluidine Blue O-embedded silicone catheters against urinary tract infection. Photodiagnosis and Photodynamic Therapy. 42. 103590–103590. 4 indexed citations
3.
Khan, Asad U., et al.. (2021). Antimicrobial and antibiofilm photodynamic therapy against vancomycin resistant Staphylococcus aureus (VRSA) induced infection in vitro and in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 160. 65–76. 41 indexed citations
4.
Khan, Shakir, et al.. (2020). Inhibition of multi-drug resistant Klebsiella pneumoniae: Nanoparticles induced photoinactivation in presence of efflux pump inhibitor. European Journal of Pharmaceutics and Biopharmaceutics. 157. 165–174. 24 indexed citations
5.
Khan, Shahper N., et al.. (2019). Synergistic fungicidal activity with low doses of eugenol and amphotericin B against Candida albicans. Biochemical and Biophysical Research Communications. 518(3). 459–464. 25 indexed citations
6.
Misba, Lama, et al.. (2019). Curcumin induced photodynamic therapy mediated suppression of quorum sensing pathway of Pseudomonas aeruginosa: An approach to inhibit biofilm in vitro. Photodiagnosis and Photodynamic Therapy. 30. 101645–101645. 74 indexed citations
7.
Sharma, Divakar, Lama Misba, & Asad U. Khan. (2019). Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrobial Resistance and Infection Control. 8(1). 76–76. 1117 indexed citations breakdown →
8.
Misba, Lama, et al.. (2019). Photodynamic efficacy of toluidine blue O against mono species and dual species bacterial biofilm. Photodiagnosis and Photodynamic Therapy. 26. 383–388. 19 indexed citations
9.
Misba, Lama, Sahar Zaidi, & Asad U. Khan. (2018). Efficacy of photodynamic therapy against Streptococcus mutans biofilm: Role of singlet oxygen. Journal of Photochemistry and Photobiology B Biology. 183. 16–21. 75 indexed citations
10.
Misba, Lama & Asad U. Khan. (2018). Enhanced Photodynamic Therapy using Light Fractionation Against Streptococcus Mutans biofilm: Type I and type II Mechanism. Future Microbiology. 13(4). 437–454. 22 indexed citations
11.
Zaidi, Sahar, Lama Misba, & Asad U. Khan. (2017). Nano-therapeutics: A revolution in infection control in post antibiotic era. Nanomedicine Nanotechnology Biology and Medicine. 13(7). 2281–2301. 138 indexed citations
12.
Misba, Lama, Sahar Zaidi, & Asad U. Khan. (2017). A comparison of antibacterial and antibiofilm efficacy of phenothiazinium dyes between Gram positive and Gram negative bacterial biofilm. Photodiagnosis and Photodynamic Therapy. 18. 24–33. 81 indexed citations
13.
Misba, Lama, et al.. (2017). CRISPR Interference (CRISPRi) Inhibition of luxS Gene Expression in E. coli: An Approach to Inhibit Biofilm. Frontiers in Cellular and Infection Microbiology. 7. 214–214. 62 indexed citations
14.
Misba, Lama, Shatavari Kulshrestha, & Asad U. Khan. (2016). Antibiofilm action of a toluidine blue O-silver nanoparticle conjugate onStreptococcus mutans: a mechanism of type I photodynamic therapy. Biofouling. 32(3). 313–328. 92 indexed citations
15.
Kulshrestha, Shatavari, et al.. (2015). Calcium fluoride nanoparticles induced suppression of Streptococcus mutans biofilm: an in vitro and in vivo approach. Applied Microbiology and Biotechnology. 100(4). 1901–1914. 113 indexed citations
16.
Mohanty, Partha Sarathi, Farah Naaz, Lama Misba, et al.. (2015). Viability of Mycobacterium leprae in the environment and its role in leprosy dissemination. Indian Journal of Dermatology Venereology and Leprology. 82(1). 23–23. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026